affected globally by incontinence
Source: World Health Organization (WHO)
Flex Skirt TECHNOLOGYTM
We develop next-gen urinary catheters focusing on patient safety, comfort, and clinical needs. Our experienced R&D team explores new technologies and materials to improve the quality of life for patients worldwide.

We collaborate with leading healthcare professionals to ensure that every catheter we develop is safe, effective, and backed by evidence-based research.
We believe in strong partnerships. Working closely with industry leaders, healthcare providers, and urological institutions, we accelerate innovation and bring better catheters to patients and caregivers.

Catheter-related complications can mean longer hospital stays, additional care and higher healthcare costs.
Of hospital-acquired urinary tract infections are associated with a urinary catheter.
Source: CDC. Approximately 75% of UTIs developed in hospitals.
Additional hospital stay associated with a catheter-associated urinary tract infection.
Source: Kelly et al., 2024. Adjusted additional stay of 3.01 days in a US hospital study.
Estimated additional hospital cost per catheter-associated urinary tract infection in the US.
Source: AHRQ, 2017. Estimated additional cost of $13,793 per CAUTI; not a current-price estimate.
Of unscheduled out-of-hours community nursing visits were catheter-related in one study.
Source: Mackay et al., 2018. Findings from a community nursing study; not a universal rate.
NowCath Foley is the first product to integrate Flex Skirt Technology. It is currently being evaluated in the REDUCE clinical trial.
